{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:03:27Z","timestamp":1778799807808,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The CTN-0067 CHOICES trial tests implementation of extended-release naltrexone (XR-NTX) versus treatment-as-usual (TAU) for opioid use disorders (OUD) in HIV clinics to improve HIV viral suppression. The study team investigated recruitment strategies to elucidate the barriers and facilitators to recruitment and enrollment in the study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Main text<\/jats:title>\n<jats:p>Methods: Semi-structured, in-depth, digitally recorded interviews were completed with study recruitment-related staff and medical providers (<jats:italic>n<\/jats:italic>\u00a0=\u200926) from six participating HIV clinics in the fall of 2018. Interviews probed 1) factors that might prevent prospective participants from engaging in study recruitment and enrollment procedures and 2) strategies used by study staff that encourage eligible patient participation. Interviews were transcribed and thematically analyzed using a content analysis approach. Results: All respondents reported that barriers to recruitment and enrollment included challenging patient social and structural factors (e.g., homelessness or living environments with high substance use, criminal justice involvement), difficulty locating patients with unsuppressed HIV viral load and OUD within the HIV clinic, time-consuming study enrollment processes, and stigma around HIV and OUD which inhibited treatment seeking. Some respondents observed that distrust of research and researchers impeded recruitment activities in the community. A specific medication-related barrier was patient fear of opioid abstinence required prior to XR-NTX induction. Facilitators of recruitment included use of trusted peer outreach\/recruitment workers in the community, hospitalizations that offered windows of opportunities for screening and XR-NTX induction, providing participant transportation, and partnerships with harm reduction organizations for referrals.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Though study personnel encountered barriers to recruitment in the CHOICES study, persons with untreated HIV and OUD can be enrolled in multisite clinical trials by using enhanced recruitment strategies that extend outside of the HIV clinic. Employing peer outreach workers and collaborating with syringe service programs may be especially helpful in facilitating recruitment and merit inclusion in similar study protocols.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12913-019-4721-x","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T11:03:15Z","timestamp":1574334195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-7881","authenticated-orcid":false,"given":"Kim A.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Needham","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula J.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"1-2","key":"4721_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drugalcdep.2010.05.009","volume":"112","author":"Nicolas Bertholet","year":"2010","unstructured":"Bertholet N, Cheng DM, Samet JH, Quinn E, Saitz R. Alcohol consumption patterns in HIV-infected adults with alcohol problems. Drug Alcohol Depend. 2010;112(1\u20132):160\u2013163. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.05.009.","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"4721_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/09540120601095734","volume":"19","author":"R. S. Braithwaite","year":"2007","unstructured":"Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, et al. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459\u2013466. https:\/\/doi.org\/https:\/\/doi.org\/10.1080\/09540120601095734.","journal-title":"AIDS Care"},{"issue":"4","key":"4721_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1468-1293.2008.00545.x","volume":"9","author":"G Chander","year":"2008","unstructured":"Chander G, Josephs J, Fleishman JA, Korthuis PT, Gaist P, Hellinger J, et al. Alcohol use among HIV-infected persons in care: results of a multi-site survey. HIV Medicine. 2008;9(4):196\u2013202. https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00545.x.","journal-title":"HIV Medicine"},{"issue":"2","key":"4721_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/QAI.0b013e31826741aa","volume":"61","author":"P. Todd Korthuis","year":"2012","unstructured":"Korthuis PT, Fiellin DA, McGinnis KA, Skanderson M, Justice AC, Gordon AJ, et al. Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care. J Acquir Immune Defic Syndr. 2012;61(2):171\u2013178. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/QAI.0b013e31826741aa.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"3","key":"4721_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jsat.2007.11.005","volume":"35","author":"Philip Todd Korthuis","year":"2008","unstructured":"Korthuis PT, Josephs JS, Fleishman JA, Hellinger J, Himelhoch S, Chander G, et al. Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. J Subst Abus Treat. 2008;35(3):294\u2013303. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jsat.2007.11.005.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"4721_CR6","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/QAI.0b013e318209d3b9","volume":"56","author":"Amina A Chaudhry","year":"2011","unstructured":"Chaudhry, A. A., Botsko, M., Weiss, L., Egan, J. E., Mitty, J., Estrada, B., \u2026 BHIVES Collaborative. (2011). Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine\/naloxone and HIV care. J Acquir Immune Defic Syndr (1999), 56 Suppl 1, S14\u2013S21. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/QAI.0b013e318209d3b9.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"Suppl 2","key":"4721_CR7","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1097\/01.mlr.0000223710.35008.d9","volume":"44","author":"Robert L. Cook","year":"2006","unstructured":"Cook RL, McGinnis KA, Kraemer KL, Gordon AJ, Conigliaro J, Maisto SA, et al. Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection. Med Care. 2006;44(8 Suppl 2):S31\u2013S36. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/01.mlr.0000223710.35008.d9.","journal-title":"Medical Care"},{"issue":"4","key":"4721_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0740-5472(99)00070-7","volume":"18","author":"MD Stein","year":"2000","unstructured":"Stein MD, Hanna L, Natarajan R, Clarke J, Marisi M, Sobota M, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abus Treat. 2000;18(4):359\u201363.","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"4721_CR9","first-page":"389","volume":"35","author":"R Andersen","year":"2000","unstructured":"Andersen R, Bozzette S, Shapiro M, St Clair P, Morton S, Crystal S, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS consortium. HIV Cost and Services Utilization Study Health Services Research. 2000;35(2):389\u2013416.","journal-title":"HIV Cost and Services Utilization Study Health Services Research"},{"issue":"2","key":"4721_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1525-1497.2001.00122.x","volume":"16","author":"RL Cook","year":"2001","unstructured":"Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16(2):83\u20138.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"4721_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.drugalcdep.2010.06.014","volume":"112","author":"Marwan M. Azar","year":"2010","unstructured":"Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178\u2013193. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.06.014.","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"4721_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1080\/09540120701351888","volume":"19","author":"P. L. Hicks","year":"2007","unstructured":"Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134\u20131140. https:\/\/doi.org\/https:\/\/doi.org\/10.1080\/09540120701351888.","journal-title":"AIDS Care"},{"issue":"3","key":"4721_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11606-012-2231-1","volume":"28","author":"Seth C. Kalichman","year":"2012","unstructured":"Kalichman SC, Grebler T, Amaral CM, McNerey M, White D, Kalichman MO, et al. Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs. J Gen Intern Med. 2013;28(3):399\u2013405. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s11606-012-2231-1.","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"4721_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/aje\/kwj059","volume":"163","author":"Gregory M. Lucas","year":"2006","unstructured":"Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol. 2006;163(5):412\u2013420. https:\/\/doi.org\/https:\/\/doi.org\/10.1093\/aje\/kwj059.","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"4721_CR15","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1097\/QAI.0b013e31820dc1c8","volume":"56","author":"Evan S Wu","year":"2011","unstructured":"Wu ES, Metzger DS, Lynch KG, Douglas SD. Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr. 2011;56(5):e129\u2013e130. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/QAI.0b013e31820dc1c8.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"7","key":"4721_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/00005650-200007000-00007","volume":"38","author":"WC Mathews","year":"2000","unstructured":"Mathews WC, McCutchan JA, Asch S, Turner BJ, Gifford AL, Kuromiya K, et al. National estimates of HIV-related symptom prevalence from the HIV cost and services utilization study. Med Care. 2000;38(7):750\u201362.","journal-title":"Med Care"},{"issue":"1","key":"4721_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10461-009-9652-9","volume":"15","author":"Enbal Shacham","year":"2009","unstructured":"Shacham E, Agbebi A, Stamm K, Overton ET. Alcohol consumption is associated with poor health in HIV clinic patient population: a behavioral surveillance study. AIDS Behav. 2011;15(1):209\u2013213. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s10461-009-9652-9.","journal-title":"AIDS and Behavior"},{"issue":"9 Suppl","key":"4721_CR18","first-page":"III40","volume":"43","author":"JA Fleishman","year":"2005","unstructured":"Fleishman JA, Gebo KA, Reilly ED, Conviser R, Christopher Mathews W, Todd Korthuis P, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care. 2005;43(9 Suppl):III40\u201352.","journal-title":"Med Care"},{"issue":"3","key":"4721_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.ALC.0000156101.84780.45","volume":"29","author":"A Palepu","year":"2005","unstructured":"Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems. Alcohol Clin Exp Res. 2005;29(3):389\u201394.","journal-title":"Alcohol Clin Exp Res"},{"key":"4721_CR20","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/QAI.0b013e318209754c","volume":"56","author":"P Todd Korthuis","year":"2011","unstructured":"Korthuis, P. Todd, Tozzi, M. J., Nandi, V., Fiellin, D. A., Weiss, L., Egan, J. E., \u2026 BHIVES Collaborative. (2011). Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. Journal of Acquired Immune Deficiency Syndromes (1999), 56 Suppl 1, S39\u201345. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/QAI.0b013e318209754c.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"4721_CR21","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","volume":"56","author":"Frederick L Altice","year":"2011","unstructured":"Altice, F. L., Bruce, R. D., Lucas, G. M., Lum, P. J., Korthuis, P. T., Flanigan, T. P., \u2026 BHIVES Collaborative. (2011). HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (1999), 56 Suppl 1, S22\u2013S32. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/QAI.0b013e318209751e.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"4721_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jsat.2010.03.005","volume":"39","author":"Joshua D. Lee","year":"2010","unstructured":"Lee JD, Grossman E, DiRocco D, Truncali A, Hanley K, Stevens D, et al. Extended-release naltrexone for treatment of alcohol dependence in primary care. J Subst Abus Treat. 2010;39(1):14\u201321. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jsat.2010.03.005.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10118","key":"4721_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","volume":"391","author":"Joshua D Lee","year":"2018","unstructured":"Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., \u2026 Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet, 391(10118), 309\u2013318. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/S0140-6736(17)32812-X.","journal-title":"The Lancet"},{"issue":"6","key":"4721_CR24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/add.13753","volume":"112","author":"Philip T. Korthuis","year":"2017","unstructured":"Korthuis, Philip T., Lum, P. J., Vergara-Rodriguez, P., Ahamad, K., Wood, E., Kunkel, L. E., \u2026 CTN-0055 CHOICES Investigators. (2017). Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot\/feasibility randomized trial. Addiction, 112(6), 1036\u20131044. https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/add.13753.","journal-title":"Addiction"},{"key":"4721_CR25","doi-asserted-by":"publisher","first-page":"100319","DOI":"10.1016\/j.conctc.2019.100319","volume":"14","author":"Ceilidh Nichols","year":"2019","unstructured":"Nichols C, Kunkel LE, Baker R, Jelstrom E, Addis M, Hoffman KA, et al. Use of single IRBs for multi-site studies: a case report and commentary from a National Drug Abuse Treatment Clinical Trials Network study. Contemporary Clinical Trials Communications. 2019;100319. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.conctc.2019.100319.","journal-title":"Contemporary Clinical Trials Communications"},{"key":"4721_CR26","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"BG Glaser","year":"1967","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research; 1967."},{"issue":"6","key":"4721_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7326\/M17-2242","volume":"169","author":"Robin M. Nance","year":"2018","unstructured":"Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, et al. HIV viral suppression trends over time among HIV-infected patients receiving Care in the United States, 1997 to 2015: a cohort study. Ann Intern Med. 2018;169(6):376\u2013384. https:\/\/doi.org\/https:\/\/doi.org\/10.7326\/M17-2242.","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"4721_CR28","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.2105\/AJPH.81.11.1498","volume":"81","author":"S B Thomas","year":"1991","unstructured":"Thomas SB, Quinn SC. The Tuskegee syphilis study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. Am J Public Health. 1991;81(11):1498\u20131505. https:\/\/doi.org\/https:\/\/doi.org\/10.2105\/AJPH.81.11.1498.","journal-title":"American Journal of Public Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-019-4721-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T01:30:18Z","timestamp":1605835818000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-019-4721-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4721"],"URL":"https:\/\/doi.org\/10.1186\/s12913-019-4721-x","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"17 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors are co-investigators on CTN-0067. Alkermes (a global biopharmaceutical company) has donated the extended-release naltrexone used in the study protocol. In addition, Dr. Korthuis serves on a separate investigation using buprenorphine donated by Indivior. Dr. Kim Hoffman is an associated editor for BMC Health Services Research. The remaining authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"862"}}